SCHEMBL752267

SCHEMBL752267

COC(=O)c1cnc(OCc2ccc([C@@H](C)[C@@](O)(c3ccnc(Cl)c3)C(F)(F)F)c(Cl)c2)nc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 5/20 0.37
KDM5A P29375 3/20 0.35
KDM5B Q9UGL1 3/20 0.35
RORC P51449 1/20 0.33
MLYCD O95822 1/20 0.33
RXRA P19793 2/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2B Q13224 1/20 0.32
FFAR1 O14842 1/20 0.32
PDK1 Q15118 2/20 0.31
PDK2 Q15119 2/20 0.31
PDK3 Q15120 2/20 0.31
PDK4 Q16654 2/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479977 1.00 MRGPRX4 (0.37) MRGPRX4KDM5AKDM5BRORCMLYCD
SCHEMBL754431 0.91 MRGPRX4 (0.37) MRGPRX4KDM5AKDM5BRXRAFFAR1
SCHEMBL480002 0.91 MRGPRX4 (0.37) MRGPRX4KDM5AKDM5BRXRAFFAR1
SCHEMBL753236 0.90 GRM5 (0.38) MRGPRX4
SCHEMBL479875 0.90 GRM5 (0.38) MRGPRX4
SCHEMBL15789701 0.90 FFAR1 (0.33) MRGPRX4RXRAGRIN1GRIN2BFFAR1
SCHEMBL15789733 0.86 FFAR1 (0.35) MRGPRX4KDM5AKDM5BRXRAGRIN1
SCHEMBL479658 0.86 KDR (0.34) PDK1PDK2PDK3PDK4NR1H2
SCHEMBL480029 0.85 MRGPRX4 (0.33) MRGPRX4KDM5AKDM5BRXRAGRIN1
SCHEMBL753013 0.85 MRGPRX4 (0.33) MRGPRX4KDM5AKDM5BRXRAGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 MRGPRX4 284/4885KDM5A 2193/4885KDM5B 3235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.